At 7.2% CAGR, Middle East & Africa Arterial Blood Gas Kits Market is Projected to be worth US$ 40,859.41 thousand by 2031, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa arterial blood gas kits market was valued at US$ 23,511.30 thousand in 2023 and is expected to reach US$ 40,859.41 thousand by 2031, recording a CAGR of 7.2% from 2023 to 2031. Increasing incidence of respiratory diseases and surging adoption of point-of-care diagnostics in emerging countries are among the critical factors attributed to drive the Middle East & Africa arterial blood gas kits market growth.

Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia lead to a huge burden on public healthcare systems in various countries across the world. Infections, smoking, and genetic factors can cause serious respiratory complications. Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death globally, resulting in 3.5 million deaths in 2021, which represents about 5% of all deaths worldwide. Approximately 90% of COPD-related deaths among individuals under 70 years of age occur in low- and middle-income countries (LMIC). The United Nations International Children's Emergency Fund (UNICEF) stated that nearly 1,400 per 100,000 children, i.e., 1 case per 71 children, are diagnosed with pneumonia every year. Breathing issues and oxygen shortages are common in patients suffering from respiratory disorders. Arterial blood gas (ABG) tests are performed to measure oxygen and carbon dioxide gases dissolved in blood. The test serves as a basis of care delivered to patients suffering from acute and chronic respiratory disease. Thus, the surging incidence of acute and chronic respiratory diseases propels the demand for arterial blood gas test kits.

On the contrary, the high cost of kits and complications associated with arterial blood sampling aids hamper the growth of Middle East & Africa arterial blood gas kits market.

Based on syringe type, the Middle East & Africa arterial blood gas kits market is bifurcated into luer slip syringe and luer lock syringe. The luer lock syringe segment held 58.4% market share in 2023, amassing US$ 13,723.26 thousand. It is projected to garner US$ 24,282.82 thousand by 2031 to register 7.4% CAGR during 2023–2031.

In terms of type, the Middle East & Africa arterial blood gas kits market is bifurcated into vented and non-vented. The vented segment held 64.9% share of Middle East & Africa arterial blood gas kits market in 2023, amassing US$ 15,261.07 thousand. It is anticipated to garner US$ 27,114.03 thousand by 2031 to expand at 7.4% CAGR during 2023–2031.

By usage, the Middle East & Africa arterial blood gas kits market is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held 74.0% share of Middle East & Africa arterial blood gas kits market in 2023, amassing US$ 17,387.19 thousand. It is projected to garner US$ 30,432.36 thousand by 2031 to expand at 7.2% CAGR from 2023 to 2031.

Based on application, the Middle East & Africa arterial blood gas kits market is bifurcated into in vitro diagnostics and electrolyte analysis. The in vitro diagnostics segment held 74.4% share of Middle East & Africa arterial blood gas kits market in 2023, amassing US$ 17,492.85 thousand. It is predicted to garner US$ 31,051.72 thousand by 2031 to expand at 7.4% CAGR between 2023 and 2031. The in vitro diagnostics segment held a larger market share in 2023. Furthermore, the in vitro diagnostics segment is sub segmented into pH blood gas, oxygen content, and others.

In terms of needle gauge, the Middle East & Africa arterial blood gas kits market is segmented into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held 46.4% share of Middle East & Africa arterial blood gas kits market in 2023, amassing US$ 10,903.91 thousand. It is estimated to garner US$ 19,524.67 thousand by 2031 to expand at 7.6% CAGR during 2023–2031.

Based on syringe volume, the Middle East & Africa arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3ml segment held 43.7% share of Middle East & Africa arterial blood gas kits market in 2023, amassing US$ 10,274.79 thousand. It is projected to garner US$ 18,744.27 thousand by 2031 to expand at 7.8% CAGR from 2023 to 2031.

By end user, the Middle East & Africa arterial blood gas kits market is categorized into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment held 54.3% share of Middle East & Africa arterial blood gas kits market in 2023, amassing US$ 12,768.61 thousand. It is projected to garner US$ 22,802.85 thousand by 2031 to expand at 7.5% CAGR from 2023 to 2031.

Based on country, the Middle East & Africa arterial blood gas kits market is segmented into South Africa, Saudi Arabia, the UAE, Kuwait, Qatar, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 33.5% share of Middle East & Africa arterial blood gas kits market in 2023. It was assessed at US$ 7,878.64 thousand in 2023 and is likely to hit US$ 13,828.71 thousand by 2031, registering a CAGR of 7.3% during 2023 to 2031.

Key players operating in the Middle East & Africa arterial blood gas kits market are Radiometer Medical ApS, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SARSTEDT AG & Co KG, and Lepu Medical Technology Beijing Co Ltd., among others.

• In January 2022, ICU Medical acquired Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. Combined with ICU Medical's existing businesses, the two companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately US$ 2.5 billion. The NeoCord ABG kit includes two labels and samplers to accommodate venous and arterial draws.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com